The microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030, By Roots Analysis
Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt these platforms for next generation biologics, offering lucrative opportunities for CMOs / CDMOs   Roots Analysis is pleased to announce the publication of its recent study, titled, “Microbial Contract Biomanufacturing Market, 2020-2030....
0 Comments 0 Shares
Sponsored